Erratum: A Phase 2 Multi-center, Open-label, Switch-over Trial to Evaluate the Safety and Efficacy of Abcertin® in Patients with Type 1 Gaucher Disease

J Korean Med Sci. 2015 Sep;30(9):1373. doi: 10.3346/jkms.2015.30.9.1373.
No abstract available

Publication types

  • Published Erratum